Literature DB >> 26721880

Binding Studies of TNF Receptor Superfamily (TNFRSF) Receptors on Intact Cells.

Isabell Lang1, Simone Füllsack1, Agnes Wyzgol1, Andrea Fick1, Johannes Trebing1, José Antonio Carmona Arana1, Viktoria Schäfer1, Daniela Weisenberger1, Harald Wajant2.   

Abstract

Ligands of the tumor necrosis factor superfamily (TNFSF) interact with members of the TNF receptor superfamily (TNFRSF). TNFSF ligand-TNFRSF receptor interactions have been intensively evaluated by many groups. The affinities of TNFSF ligand-TNFRSF receptor interactions are highly dependent on the oligomerization state of the receptor, and cellular factors (e.g. actin cytoskeleton and lipid rafts) influence the assembly of ligand-receptor complexes, too. Binding studies on TNFSF ligand-TNFRSF receptor interactions were typically performed using cell-free assays with recombinant fusion proteins that contain varying numbers of TNFRSF ectodomains. It is therefore not surprising that affinities determined for an individual TNFSF ligand-TNFRSF interaction differ sometimes by several orders of magnitude and often do not reflect the ligand activity observed in cellular assays. To overcome the intrinsic limitations of cell-free binding studies and usage of recombinant receptor domains, we performed comprehensive binding studies with Gaussia princeps luciferase TNFSF ligand fusion proteins for cell-bound TNFRSF members on intact cells at 37 °C. The affinities of the TNFSF ligand G. princeps luciferase-fusion proteins ranged between 0.01 and 19 nm and offer the currently most comprehensive and best suited panel of affinities for in silico studies of ligand-receptor systems of the TNF family.
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  NF-κB (NF-KB); TNF receptor-associated factor; cytokine; fusion protein; ligand-binding protein; protein complex; receptor regulation; tumor necrosis factor (TNF)

Mesh:

Substances:

Year:  2015        PMID: 26721880      PMCID: PMC4777839          DOI: 10.1074/jbc.M115.683946

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  70 in total

1.  Temperature-sensitive differential affinity of TRAIL for its receptors. DR5 is the highest affinity receptor.

Authors:  A Truneh; S Sharma; C Silverman; S Khandekar; M P Reddy; K C Deen; M M McLaughlin; S M Srinivasula; G P Livi; L A Marshall; E S Alnemri; W V Williams; M L Doyle
Journal:  J Biol Chem       Date:  2000-07-28       Impact factor: 5.157

2.  TACI, unlike BAFF-R, is solely activated by oligomeric BAFF and APRIL to support survival of activated B cells and plasmablasts.

Authors:  Claudia Bossen; Teresa G Cachero; Aubry Tardivel; Karine Ingold; Laure Willen; Max Dobles; Martin L Scott; Aris Maquelin; Elodie Belnoue; Claire-Anne Siegrist; Stéphane Chevrier; Hans Acha-Orbea; Helen Leung; Fabienne Mackay; Jürg Tschopp; Pascal Schneider
Journal:  Blood       Date:  2007-10-17       Impact factor: 22.113

Review 3.  Engineering death receptor ligands for cancer therapy.

Authors:  Harald Wajant; Jeannette Gerspach; Klaus Pfizenmaier
Journal:  Cancer Lett       Date:  2011-01-14       Impact factor: 8.679

4.  Expression and purification of a natural N-terminal pre-ligand assembly domain of tumor necrosis factor receptor 1 (TNFR1 PLAD) and preliminary activity determination.

Authors:  Jin Cao; Fang Meng; Xiangdong Gao; Hongxia Dong; Wenbing Yao
Journal:  Protein J       Date:  2011-04       Impact factor: 2.371

5.  Expression, purification, and characterization of the human receptor activator of NF-kappaB ligand (RANKL) extracellular domain.

Authors:  D Willard; W J Chen; G Barrett; K Blackburn; J Bynum; T Consler; C Hoffman; E Horne; M A Iannone; S Kadwell; J Parham; B Ellis
Journal:  Protein Expr Purif       Date:  2000-10       Impact factor: 1.650

6.  CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF.

Authors:  C A Smith; H J Gruss; T Davis; D Anderson; T Farrah; E Baker; G R Sutherland; C I Brannan; N G Copeland; N A Jenkins
Journal:  Cell       Date:  1993-07-02       Impact factor: 41.582

7.  TWEAK binding to the Fn14 cysteine-rich domain depends on charged residues located in both the A1 and D2 modules.

Authors:  Sharron A N Brown; Heather N Hanscom; Hong Vu; Shelesa A Brew; Jeffrey A Winkles
Journal:  Biochem J       Date:  2006-07-15       Impact factor: 3.857

8.  Assembly and structural properties of glucocorticoid-induced TNF receptor ligand: Implications for function.

Authors:  Kausik Chattopadhyay; Udupi A Ramagopal; Arunika Mukhopadhaya; Vladimir N Malashkevich; Teresa P Dilorenzo; Michael Brenowitz; Stanley G Nathenson; Steven C Almo
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-26       Impact factor: 11.205

9.  Activity of soluble OX40 ligand is enhanced by oligomerization and cell surface immobilization.

Authors:  Nicole Müller; Agnes Wyzgol; Sabine Münkel; Klaus Pfizenmaier; Harald Wajant
Journal:  FEBS J       Date:  2008-04-03       Impact factor: 5.542

10.  Membrane tumor necrosis factor (TNF) induces p100 processing via TNF receptor-2 (TNFR2).

Authors:  Hilka Rauert; Andreas Wicovsky; Nicole Müller; Daniela Siegmund; Volker Spindler; Jens Waschke; Christian Kneitz; Harald Wajant
Journal:  J Biol Chem       Date:  2009-12-28       Impact factor: 5.157

View more
  20 in total

1.  Quantitative analysis of cell surface antigen-antibody interaction using Gaussia princeps luciferase antibody fusion proteins.

Authors:  Juliane Kums; Johannes Nelke; Benedikt Rüth; Viktoria Schäfer; Daniela Siegmund; Harald Wajant
Journal:  MAbs       Date:  2017-01-17       Impact factor: 5.857

2.  Advancing targeted co-stimulation with antibody-fusion proteins by introducing TNF superfamily members in a single-chain format.

Authors:  Sina Fellermeier; Nadine Beha; Jan-Erik Meyer; Sarah Ring; Stefan Bader; Roland E Kontermann; Dafne Müller
Journal:  Oncoimmunology       Date:  2016-09-27       Impact factor: 8.110

3.  Butyltin compounds alter secretion of interleukin 6 from human immune cells.

Authors:  Shyretha Brown; Wendy Wilburn; Tyesha Martin; Margaret Whalen
Journal:  J Appl Toxicol       Date:  2017-08-24       Impact factor: 3.446

4.  Both HIV-Infected and Uninfected Cells Express TRAILshort, Which Confers TRAIL Resistance upon Bystander Cells within the Microenvironment.

Authors:  Zilin Nie; Fatma Aboulnasr; Sekar Natesampillai; Stephen P Burke; Ashton Krogman; Gary D Bren; Thomas D Y Chung; Jeff R Anderson; Michele K Smart; David J Katzmann; Govindarajan Rajagopalan; Nathan W Cummins; Andrew D Badley
Journal:  J Immunol       Date:  2017-12-20       Impact factor: 5.422

5.  How does the same ligand activate signaling of different receptors in TNFR superfamily: a computational study.

Authors:  Zhaoqian Su; Yinghao Wu
Journal:  J Cell Commun Signal       Date:  2022-09-28       Impact factor: 5.908

6.  T-cell trans-synaptic vesicles are distinct and carry greater effector content than constitutive extracellular vesicles.

Authors:  Pablo F Céspedes; Ashwin Jainarayanan; Lola Fernández-Messina; Salvatore Valvo; David G Saliba; Elke Kurz; Audun Kvalvaag; Lina Chen; Charity Ganskow; Huw Colin-York; Marco Fritzsche; Yanchun Peng; Tao Dong; Errin Johnson; Jesús A Siller-Farfán; Omer Dushek; Erdinc Sezgin; Ben Peacock; Alice Law; Dimitri Aubert; Simon Engledow; Moustafa Attar; Svenja Hester; Roman Fischer; Francisco Sánchez-Madrid; Michael L Dustin
Journal:  Nat Commun       Date:  2022-06-16       Impact factor: 17.694

Review 7.  Visceral adiposity, inflammation, and hippocampal function in obesity.

Authors:  Alexis M Stranahan
Journal:  Neuropharmacology       Date:  2021-12-10       Impact factor: 5.273

8.  Controlled Modular Multivalent Presentation of the CD40 Ligand on P22 Virus-like Particles Leads to Tunable Amplification of CD40 Signaling.

Authors:  Cheri Peyton Goodall; Benjamin Schwarz; Ekaterina Selivanovitch; John Avera; Joseph Wang; Heini Miettinen; Trevor Douglas
Journal:  ACS Appl Bio Mater       Date:  2021-11-10

9.  Crystal structure of murine 4-1BB and its interaction with 4-1BBL support a role for galectin-9 in 4-1BB signaling.

Authors:  Aruna Bitra; Tzanko Doukov; Jing Wang; Gaelle Picarda; Chris A Benedict; Michael Croft; Dirk M Zajonc
Journal:  J Biol Chem       Date:  2017-12-14       Impact factor: 5.157

10.  Brefeldin A-Inhibited Guanine Nucleotide-Exchange Factor 1 (BIG1) Governs the Recruitment of Tumor Necrosis Factor Receptor-Associated Factor 2 (TRAF2) to Tumor Necrosis Factor Receptor 1 (TNFR1) Signaling Complexes.

Authors:  Takuya Noguchi; Mei Tsuchida; Yosuke Kogue; Christian Spadini; Yusuke Hirata; Atsushi Matsuzawa
Journal:  Int J Mol Sci       Date:  2016-11-09       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.